|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
|
EP1071658B1
(en)
|
1998-04-17 |
2004-06-16 |
Parker Hughes Institute |
Btk inhibitors and methods for their identification and use
|
|
CA2338121A1
(en)
|
1998-08-04 |
2000-02-17 |
Astrazeneca Ab |
Amide derivatives useful as inhibitors of the production of cytokines
|
|
EP1115707B1
(en)
|
1998-09-25 |
2003-11-12 |
AstraZeneca AB |
Benzamide derivatives and ther use as cytokine inhibitors
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
CA2385747A1
(en)
|
1999-09-17 |
2001-03-22 |
Gavin C. Hirst |
Pyrazolopyrimidines as therapeutic agents
|
|
ES2367422T3
(es)
|
2001-10-09 |
2011-11-03 |
Amgen Inc. |
Derivados de imidazol como agentes antiinflamatorios.
|
|
MXPA05001804A
(es)
*
|
2002-08-14 |
2005-05-27 |
Vertex Pharma |
Inhibidores de proteinas cinasas y usos de los mismos.
|
|
MXPA05006033A
(es)
|
2002-12-05 |
2006-03-08 |
Univ Arkansas |
Determinantes moleculares de enfermedad osea por mieloma, y usos de los mismos.
|
|
SI1569907T1
(sl)
|
2002-12-13 |
2016-06-30 |
Ym Biosciences Australia Pty Ltd |
Na nikotinamidu osnovani kinazni inhibitorji
|
|
US20070281907A1
(en)
|
2003-12-22 |
2007-12-06 |
Watkins William J |
Kinase Inhibitor Phosphonate Conjugates
|
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
KR20070094802A
(ko)
|
2004-12-20 |
2007-09-21 |
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. |
ＭｙＤ８８ 동종이량체화 억제제
|
|
UY29300A1
(es)
|
2004-12-22 |
2006-07-31 |
Astrazeneca Ab |
Compuestos quimicos
|
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
|
RU2368602C2
(ru)
|
2005-01-26 |
2009-09-27 |
Айрм Ллк |
Соединения и композиции в качестве ингибиторов протеинкиназ
|
|
AU2006278627B2
(en)
|
2005-08-08 |
2011-08-18 |
Janssen Pharmaceutica, N.V. |
Thiazolopyrimidine kinase inhibitors
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
GT200600411A
(es)
|
2005-09-13 |
2007-05-21 |
Novartis Ag |
Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular
|
|
US8101610B2
(en)
|
2005-11-14 |
2012-01-24 |
Genentech, Inc. |
Bisamide inhibitors of hedgehog signaling
|
|
JP2009520784A
(ja)
|
2005-12-22 |
2009-05-28 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体、その製造方法および抗癌剤としてのその使用
|
|
US20070155746A1
(en)
*
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
GB0605120D0
(en)
|
2006-03-14 |
2006-04-26 |
Novartis Ag |
Organic Compounds
|
|
US20090312396A1
(en)
*
|
2006-07-10 |
2009-12-17 |
Astrazeneca Ab |
Methods for cancer treatment using tak1 inhibitors
|
|
BRPI0622054B8
(pt)
|
2006-09-22 |
2021-05-25 |
Oxford Amherst Llc |
composto e composição farmacêutica
|
|
KR101722261B1
(ko)
|
2006-10-02 |
2017-04-03 |
메다렉스, 엘.엘.시. |
Ｃｘｃｒ4에 결합하는 인간 항체 및 이의 용도
|
|
US20120065201A1
(en)
|
2007-03-28 |
2012-03-15 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
CA2683049A1
(en)
|
2007-04-17 |
2008-10-23 |
Novartis Ag |
Organic compounds
|
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
TW200906825A
(en)
|
2007-05-30 |
2009-02-16 |
Scripps Research Inst |
Inhibitors of protein kinases
|
|
AU2008282728B2
(en)
|
2007-08-02 |
2012-04-19 |
Amgen Inc. |
Pl3 kinase modulators and methods of use
|
|
CN105367503A
(zh)
|
2007-10-19 |
2016-03-02 |
阿维拉制药公司 |
杂芳基化合物和其用途
|
|
US7989465B2
(en)
|
2007-10-19 |
2011-08-02 |
Avila Therapeutics, Inc. |
4,6-disubstituted pyrimidines useful as kinase inhibitors
|
|
EP2508523B2
(en)
|
2007-10-23 |
2019-04-17 |
Teva Pharmaceutical Industries Ltd. |
Polymorphs of dasatinib and process for preparation thereof
|
|
US8394816B2
(en)
|
2007-12-07 |
2013-03-12 |
Irene Ghobrial |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
|
|
EP2222166B9
(en)
|
2007-12-10 |
2012-11-07 |
Concert Pharmaceuticals Inc. |
Heterocyclic kinase inhibitors
|
|
US8426424B2
(en)
|
2008-05-06 |
2013-04-23 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
TWI546290B
(zh)
*
|
2008-06-27 |
2016-08-21 |
賽基艾維洛米斯研究股份有限公司 |
雜芳基化合物及其用途
|
|
US7824861B2
(en)
|
2008-07-10 |
2010-11-02 |
National Tsing Hua University |
Method for quantitative analysis of transcripts with nucleotide polymorphism at specific site
|
|
DK2319830T3
(en)
|
2008-08-13 |
2017-02-13 |
Mitsui Chemicals Agro Inc |
Amide derivative, pesticide containing the amide derivative and use of the pesticide
|
|
AU2009289378A1
(en)
*
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
WO2010056875A1
(en)
|
2008-11-12 |
2010-05-20 |
Cgi Pharmaceuticals, Inc. |
Pyridazinones and their use as btk inhibitors
|
|
AU2009329994B2
(en)
|
2008-12-23 |
2014-04-03 |
Genentech, Inc. |
Methods and compositions for diagnostic use in cancer patients
|
|
IN2012DN02493A
(2)
|
2009-09-03 |
2015-08-28 |
Allergan Inc |
|
|
US9029359B2
(en)
|
2009-09-04 |
2015-05-12 |
Biogen Idec Ma, Inc. |
Heteroaryl Btk inhibitors
|
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
|
CA2787291C
(en)
|
2010-02-08 |
2016-04-19 |
Msd Oss B.V. |
8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
|
|
US20120071497A1
(en)
|
2010-06-03 |
2012-03-22 |
Pharmacyclics, Inc. |
Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
|
|
JP5985473B2
(ja)
|
2010-07-13 |
2016-09-06 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ＩＲＡＫ４モジュレーターとしてのピラゾロ［１，５ａ］ピリミジン及びチエノ［３，２ｂ］ピリミジン誘導体
|
|
AU2011328237A1
(en)
|
2010-11-09 |
2013-05-23 |
Cellzome Limited |
Pyridine compounds and aza analogues thereof as TYK2 inhibitors
|
|
US20140080810A1
(en)
|
2010-11-15 |
2014-03-20 |
Exelixis, Inc. |
Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
|
|
WO2012161877A1
(en)
|
2011-05-23 |
2012-11-29 |
Merck Patent Gmbh |
Pyridine-and pyrazine derivatives
|
|
KR20180084153A
(ko)
|
2011-06-10 |
2018-07-24 |
메르크 파텐트 게엠베하 |
Btk 억제 활성을 갖는 피리미딘 및 피리딘 화합물의 조성물 및 제조방법
|
|
US10465247B2
(en)
|
2011-07-01 |
2019-11-05 |
Dana-Farber Cancer Institute, Inc. |
Discovery of a somatic mutation in MYD88 gene in lymphoplasmacytic lymphoma
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
MX2014003994A
(es)
|
2011-10-03 |
2014-05-07 |
Syngenta Participations Ag |
Derivados insecticidas de 2-metoxobenzamida.
|
|
JP2014528451A
(ja)
|
2011-10-04 |
2014-10-27 |
ギリアード カリストガ エルエルシー |
Ｐｉ３ｋの新規キノキサリン阻害剤
|
|
MX2014005289A
(es)
|
2011-11-03 |
2014-05-30 |
Hoffmann La Roche |
Compuestos de piperazina alquilados.
|
|
SG11201401386XA
(en)
|
2011-11-09 |
2014-10-30 |
Bristol Myers Squibb Co |
Treatment of hematologic malignancies with an anti-cxcr4 antibody
|
|
CA2856291C
(en)
|
2011-11-17 |
2020-08-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
|
DK2790705T3
(en)
|
2011-12-15 |
2018-03-12 |
Novartis Ag |
Use of inhibitors of the activity or function of PI3K
|
|
US9604988B2
(en)
|
2012-07-27 |
2017-03-28 |
Riken |
Agent for treating or inhibiting recurrence of acute myeloid leukemia
|
|
CN103405429A
(zh)
|
2013-08-22 |
2013-11-27 |
中国药科大学 |
一类vegfr-2抑制剂及其用途
|
|
CA3206628A1
(en)
|
2013-09-12 |
2015-03-19 |
Dana-Farber Cancer Institute, Inc. |
Methods for evaluating and treating waldenstrom's macroglobulinemia
|
|
WO2015069287A1
(en)
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
EP3077001B1
(en)
|
2013-12-06 |
2020-04-15 |
Dana-Farber Cancer Institute, Inc. |
Methods to distinguish waldenström's macroglobulinemia from igm monoclonal gammopathy of undetermined significance
|
|
EP3079682A4
(en)
|
2013-12-13 |
2017-08-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
US9856223B2
(en)
|
2013-12-13 |
2018-01-02 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
WO2016055982A1
(en)
|
2014-10-10 |
2016-04-14 |
Acerta Pharma B.V. |
Quinoline and quinazoline compounds
|
|
US10112957B2
(en)
|
2014-10-22 |
2018-10-30 |
Dana-Farber Cancer Institute, Inc. |
Thiazolyl-containing compounds for treating proliferative diseases
|
|
RU2726367C2
(ru)
|
2016-03-28 |
2020-07-13 |
Пресидж Байосайенсиз, Инк. |
Фармацевтические комбинации для лечения злокачественной опухоли
|
|
CA3019182A1
(en)
|
2016-04-29 |
2017-11-02 |
Dana-Farber Cancer Institute, Inc. |
Hck as a therapeutic target in myd88 mutated diseases
|
|
CN106008371A
(zh)
|
2016-06-24 |
2016-10-12 |
谢阳 |
1-芳基脲基环烷基-1-甲酰胺类化合物及其药物组合物和应用
|
|
CN106279120A
(zh)
|
2016-07-15 |
2017-01-04 |
谢阳 |
一种n‑芳基氨基甲酰基脯氨酸类化合物及其药物组合物和应用
|
|
CN107056786B
(zh)
|
2016-10-14 |
2019-05-07 |
苏州明锐医药科技有限公司 |
阿卡替尼的制备方法
|
|
EP3630778A1
(en)
|
2017-05-26 |
2020-04-08 |
Ichnos Sciences SA |
Novel inhibitors of map4k1
|
|
WO2021071922A1
(en)
|
2019-10-08 |
2021-04-15 |
Dana-Farber Cancer Institute, Inc. |
A pyrazolopyrimidine derivative as a hck inhibitor for use in therapy, in particular myd88 mutated diseases
|
|
WO2021071919A1
(en)
|
2019-10-08 |
2021-04-15 |
Dana-Farber Cancer Institute, Inc. |
Hck as a therapeutic target in myd88 mutated diseases
|